Literature DB >> 28705383

Ischemic or Nonischemic Functional Mitral Regurgitation and Outcomes in Patients With Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.

Katsuya Kajimoto1, Yuichiro Minami2, Shigeru Otsubo3, Naoki Sato4.   

Abstract

The aim of this study was to evaluate the association of functional mitral regurgitation (FMR), preserved or reduced ejection fraction (EF), and ischemic or nonischemic origin with outcomes in patients discharged alive after hospitalization for acute decompensated heart failure (HF). Of the 4,842 patients enrolled in the Acute Decompensated Heart Failure Syndromes (ATTEND) registry, 3,357 patients were evaluated to assess the association of FMR, preserved or reduced EF, and ischemic or nonischemic origin with the primary end point (all-cause death and readmission for HF after discharge). At the time of discharge, FMR was assessed semiquantitatively (classified as none, mild, or moderate to severe) by color Doppler analysis of the regurgitant jet area. According to multivariable analysis, in the ischemic group, either mild or moderate to severe FMR in patients with a preserved EF had a significantly higher risk of the primary end point than patients without FMR (hazard ratio [HR] 1.60; 95% confidence interval [CI] 1.12 to 2.29; p = 0.010 and HR 1.98; 95% CI 1.30 to 3.01; p = 0.001, respectively). In patients with reduced EF with an ischemic origin, only moderate to severe FMR was associated with a significantly higher risk of the primary end point (HR 1.67; 95% CI 1.11 to 2.50; p = 0.014). In the nonischemic group, there was no significant association between FMR and the primary end point in patients with either a preserved or reduced EF. In conclusion, among patients with acute decompensated HF with a preserved or reduced EF, the association of FMR with adverse outcomes may differ between patients who had an ischemic or nonischemic origin of HF.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28705383     DOI: 10.1016/j.amjcard.2017.05.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Prognostic significance of residual functional mitral regurgitation in hospitalized heart failure patients with chronic atrial fibrillation and preserved ejection fraction after medical therapies.

Authors:  Kazato Ito; Yukio Abe; Hiroyuki Watanabe; Yoshihisa Shimada; Kentaro Shibayama; Hiroki Oe; Eiichi Hyodo; Chinami Miyazaki; Yosuke Takahashi; Toshihiko Shibata; Hiroshi Ito
Journal:  J Echocardiogr       Date:  2018-12-19

2.  Mitral regurgitation severity dynamic during acute decompensated heart failure treatment.

Authors:  Kamil Bugała; Paweł Rubiś; Mateusz K Hołda; Małgorzata Konieczyńska; Piotr Bijak; Wojciech Płazak
Journal:  Int J Cardiovasc Imaging       Date:  2021-12-22       Impact factor: 2.357

Review 3.  Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis.

Authors:  Riccardo M Inciardi; Andrea Rossi; Giovanni Benfari; Mariantonietta Cicoira
Journal:  Curr Heart Fail Rep       Date:  2018-04

4.  Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study.

Authors:  Sameer Arora; Krishan Sivaraj; Michael Hendrickson; Patricia P Chang; Thelsa Weickert; Arman Qamar; Muthiah Vaduganathan; Melissa C Caughey; Ambarish Pandey; Matthew A Cavender; Wayne Rosamond; John P Vavalle
Journal:  JACC Heart Fail       Date:  2020-12-09       Impact factor: 12.035

5.  Severity of Functional Mitral Regurgitation on Admission for Acute Decompensated Heart Failure Predicts Long-Term Risk of Rehospitalization and Death.

Authors:  Rachna Kataria; Francesco Castagna; Shivank Madan; Paul Kim; Omar Saeed; Yaw A Adjepong; Angelos A Melainis; Cynthia Taub; Mario J Garcia; Azeem Latib; Ulrich P Jorde
Journal:  J Am Heart Assoc       Date:  2021-12-22       Impact factor: 5.501

6.  Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure.

Authors:  Matteo Pagnesi; Marianna Adamo; Iziah E Sama; Stefan D Anker; John G Cleland; Kenneth Dickstein; Gerasimos S Filippatos; Riccardo M Inciardi; Chim C Lang; Carlo M Lombardi; Leong L Ng; Piotr Ponikowski; Nilesh J Samani; Faiez Zannad; Dirk J van Veldhuisen; Adriaan A Voors; Marco Metra
Journal:  Clin Res Cardiol       Date:  2022-03-16       Impact factor: 6.138

7.  Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation.

Authors:  Kaeko Hirai; Rika Kawakami; Maki Nogi; Satomi Ishihara; Yukihiro Hashimoto; Yasuki Nakada; Hitoshi Nakagawa; Tomoya Ueda; Taku Nishida; Kenji Onoue; Tsunenari Soeda; Satoshi Okayama; Makoto Watanabe; Hiroyuki Okura; Yoshihiko Saito
Journal:  Circ Rep       Date:  2021-06-12

8.  Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF.

Authors:  Matteo Pagnesi; Marianna Adamo; Iziah E Sama; Stefan D Anker; John G Cleland; Kenneth Dickstein; Gerasimos S Filippatos; Chim C Lang; Leong L Ng; Piotr Ponikowski; Alice Ravera; Nilesh J Samani; Faiez Zannad; Dirk J van Veldhuisen; Adriaan A Voors; Marco Metra
Journal:  Eur J Heart Fail       Date:  2021-08-01       Impact factor: 17.349

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.